Selected research
Industry Growth & Trends
Global Hemorrhoid Cream and Injector Industry Growth and Trends Forecast to 2032
Market perspective
The global Hemorrhoid Cream and Injector market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Hemorrhoid Cream and Injector is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Hemorrhoid Cream and Injector is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hemorrhoid Cream and Injector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hemorrhoid Cream and Injector include Yunnan Baiyao Group, Xiuzheng Pharmaceutical Group, Takeda Pharmaceutical, Mayinglong Pharmaceutical Group, Tucks, Sun Pharma, Prestige Consumer Healthcare, Naticura and Medline Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Hemorrhoid Cream and Injector market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hemorrhoid Cream and Injector market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemorrhoid Cream and Injector market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemorrhoid Cream and Injector.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Hemorrhoid Cream and Injector market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hemorrhoid Cream and Injector Market by Company
Yunnan Baiyao Group
Xiuzheng Pharmaceutical Group
Takeda Pharmaceutical
Mayinglong Pharmaceutical Group
Tucks
Sun Pharma
Prestige Consumer Healthcare
Naticura
Medline Industries
Ferndale Healthcare
eXroid
Doctor Bulter’s
Church and Dwight
Bausch Health
AdvaCare Pharma
Hemorrhoid Cream and Injector Segment by Type
Prescription Drug
Over-The-Counter Drug
Hemorrhoid Cream and Injector Segment by Application
Hospital
Household Use
Others
Hemorrhoid Cream and Injector Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemorrhoid Cream and Injector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemorrhoid Cream and Injector and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemorrhoid Cream and Injector.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemorrhoid Cream and Injector manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hemorrhoid Cream and Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Drug
- Over-The-Counter Drug
Applications
- Hospital
- Household Use
- Others
Companies covered
- Yunnan Baiyao Group
- Xiuzheng Pharmaceutical Group
- Takeda Pharmaceutical
- Mayinglong Pharmaceutical Group
- Tucks
- Sun Pharma
- Prestige Consumer Healthcare
- Naticura
- Medline Industries
- Ferndale Healthcare
- eXroid
- Doctor Bulter’s
- Church and Dwight
- Bausch Health
- AdvaCare Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hemorrhoid Cream and Injector Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hemorrhoid Cream and Injector Sales Estimates and Forecasts (2021-2032)
- 1.3 Hemorrhoid Cream and Injector Market by Type
- 1.3.1 Prescription Drug
- 1.3.2 Over-The-Counter Drug
- 1.4 Global Hemorrhoid Cream and Injector Market Size by Type
- 1.4.1 Global Hemorrhoid Cream and Injector Market Size Overview by Type (2021-2032)
- 1.4.2 Global Hemorrhoid Cream and Injector Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Hemorrhoid Cream and Injector Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Hemorrhoid Cream and Injector Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Hemorrhoid Cream and Injector Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Hemorrhoid Cream and Injector Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Hemorrhoid Cream and Injector Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Hemorrhoid Cream and Injector Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Hemorrhoid Cream and Injector Industry Trends
- 2.2 Hemorrhoid Cream and Injector Industry Drivers
- 2.3 Hemorrhoid Cream and Injector Industry Opportunities and Challenges
- 2.4 Hemorrhoid Cream and Injector Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Hemorrhoid Cream and Injector Revenue (2021-2026)
- 3.2 Global Top Players by Hemorrhoid Cream and Injector Sales (2021-2026)
- 3.3 Global Top Players by Hemorrhoid Cream and Injector Price (2021-2026)
- 3.4 Global Hemorrhoid Cream and Injector Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hemorrhoid Cream and Injector Major Company Production Sites & Headquarters
- 3.6 Global Hemorrhoid Cream and Injector Company, Product Type & Application
- 3.7 Global Hemorrhoid Cream and Injector Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hemorrhoid Cream and Injector Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hemorrhoid Cream and Injector Players Market Share by Revenue in 2025
- 3.8.3 2025 Hemorrhoid Cream and Injector Tier 1, Tier 2, and Tier 3
4 Hemorrhoid Cream and Injector Regional Status and Outlook
- 4.1 Global Hemorrhoid Cream and Injector Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Hemorrhoid Cream and Injector Historic Market Size by Region
- 4.2.1 Global Hemorrhoid Cream and Injector Sales in Volume by Region (2021-2026)
- 4.2.2 Global Hemorrhoid Cream and Injector Sales in Value by Region (2021-2026)
- 4.2.3 Global Hemorrhoid Cream and Injector Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Hemorrhoid Cream and Injector Forecasted Market Size by Region
- 4.3.1 Global Hemorrhoid Cream and Injector Sales in Volume by Region (2027-2032)
- 4.3.2 Global Hemorrhoid Cream and Injector Sales in Value by Region (2027-2032)
- 4.3.3 Global Hemorrhoid Cream and Injector Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemorrhoid Cream and Injector by Application
- 5.1 Hemorrhoid Cream and Injector Market by Application
- 5.1.1 Hospital
- 5.1.2 Household Use
- 5.1.3 Others
- 5.2 Global Hemorrhoid Cream and Injector Market Size by Application
- 5.2.1 Global Hemorrhoid Cream and Injector Market Size Overview by Application (2021-2032)
- 5.2.2 Global Hemorrhoid Cream and Injector Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Hemorrhoid Cream and Injector Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Hemorrhoid Cream and Injector Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Hemorrhoid Cream and Injector Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Hemorrhoid Cream and Injector Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Hemorrhoid Cream and Injector Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Hemorrhoid Cream and Injector Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yunnan Baiyao Group
- 6.1.1 Yunnan Baiyao Group Company Information
- 6.1.2 Yunnan Baiyao Group Business Overview
- 6.1.3 Yunnan Baiyao Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yunnan Baiyao Group Hemorrhoid Cream and Injector Product Portfolio
- 6.1.5 Yunnan Baiyao Group Recent Developments
- 6.2 Xiuzheng Pharmaceutical Group
- 6.2.1 Xiuzheng Pharmaceutical Group Company Information
- 6.2.2 Xiuzheng Pharmaceutical Group Business Overview
- 6.2.3 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
- 6.2.5 Xiuzheng Pharmaceutical Group Recent Developments
- 6.3 Takeda Pharmaceutical
- 6.3.1 Takeda Pharmaceutical Company Information
- 6.3.2 Takeda Pharmaceutical Business Overview
- 6.3.3 Takeda Pharmaceutical Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Takeda Pharmaceutical Hemorrhoid Cream and Injector Product Portfolio
- 6.3.5 Takeda Pharmaceutical Recent Developments
- 6.4 Mayinglong Pharmaceutical Group
- 6.4.1 Mayinglong Pharmaceutical Group Company Information
- 6.4.2 Mayinglong Pharmaceutical Group Business Overview
- 6.4.3 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
- 6.4.5 Mayinglong Pharmaceutical Group Recent Developments
- 6.5 Tucks
- 6.5.1 Tucks Company Information
- 6.5.2 Tucks Business Overview
- 6.5.3 Tucks Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Tucks Hemorrhoid Cream and Injector Product Portfolio
- 6.5.5 Tucks Recent Developments
- 6.6 Sun Pharma
- 6.6.1 Sun Pharma Company Information
- 6.6.2 Sun Pharma Business Overview
- 6.6.3 Sun Pharma Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sun Pharma Hemorrhoid Cream and Injector Product Portfolio
- 6.6.5 Sun Pharma Recent Developments
- 6.7 Prestige Consumer Healthcare
- 6.7.1 Prestige Consumer Healthcare Company Information
- 6.7.2 Prestige Consumer Healthcare Business Overview
- 6.7.3 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Product Portfolio
- 6.7.5 Prestige Consumer Healthcare Recent Developments
- 6.8 Naticura
- 6.8.1 Naticura Company Information
- 6.8.2 Naticura Business Overview
- 6.8.3 Naticura Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Naticura Hemorrhoid Cream and Injector Product Portfolio
- 6.8.5 Naticura Recent Developments
- 6.9 Medline Industries
- 6.9.1 Medline Industries Company Information
- 6.9.2 Medline Industries Business Overview
- 6.9.3 Medline Industries Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Medline Industries Hemorrhoid Cream and Injector Product Portfolio
- 6.9.5 Medline Industries Recent Developments
- 6.10 Ferndale Healthcare
- 6.10.1 Ferndale Healthcare Company Information
- 6.10.2 Ferndale Healthcare Business Overview
- 6.10.3 Ferndale Healthcare Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Ferndale Healthcare Hemorrhoid Cream and Injector Product Portfolio
- 6.10.5 Ferndale Healthcare Recent Developments
- 6.11 eXroid
- 6.11.1 eXroid Company Information
- 6.11.2 eXroid Business Overview
- 6.11.3 eXroid Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 eXroid Hemorrhoid Cream and Injector Product Portfolio
- 6.11.5 eXroid Recent Developments
- 6.12 Doctor Bulter’s
- 6.12.1 Doctor Bulter’s Company Information
- 6.12.2 Doctor Bulter’s Business Overview
- 6.12.3 Doctor Bulter’s Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Doctor Bulter’s Hemorrhoid Cream and Injector Product Portfolio
- 6.12.5 Doctor Bulter’s Recent Developments
- 6.13 Church and Dwight
- 6.13.1 Church and Dwight Company Information
- 6.13.2 Church and Dwight Business Overview
- 6.13.3 Church and Dwight Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Church and Dwight Hemorrhoid Cream and Injector Product Portfolio
- 6.13.5 Church and Dwight Recent Developments
- 6.14 Bausch Health
- 6.14.1 Bausch Health Company Information
- 6.14.2 Bausch Health Business Overview
- 6.14.3 Bausch Health Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Bausch Health Hemorrhoid Cream and Injector Product Portfolio
- 6.14.5 Bausch Health Recent Developments
- 6.15 AdvaCare Pharma
- 6.15.1 AdvaCare Pharma Company Information
- 6.15.2 AdvaCare Pharma Business Overview
- 6.15.3 AdvaCare Pharma Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 AdvaCare Pharma Hemorrhoid Cream and Injector Product Portfolio
- 6.15.5 AdvaCare Pharma Recent Developments
7 North America by Country
- 7.1 North America Hemorrhoid Cream and Injector Sales by Country
- 7.1.1 North America Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Hemorrhoid Cream and Injector Sales by Country (2021-2026)
- 7.1.3 North America Hemorrhoid Cream and Injector Sales Forecast by Country (2027-2032)
- 7.2 North America Hemorrhoid Cream and Injector Market Size by Country
- 7.2.1 North America Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Hemorrhoid Cream and Injector Market Size by Country (2021-2026)
- 7.2.3 North America Hemorrhoid Cream and Injector Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Hemorrhoid Cream and Injector Sales by Country
- 8.1.1 Europe Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Hemorrhoid Cream and Injector Sales by Country (2021-2026)
- 8.1.3 Europe Hemorrhoid Cream and Injector Sales Forecast by Country (2027-2032)
- 8.2 Europe Hemorrhoid Cream and Injector Market Size by Country
- 8.2.1 Europe Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Hemorrhoid Cream and Injector Market Size by Country (2021-2026)
- 8.2.3 Europe Hemorrhoid Cream and Injector Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Hemorrhoid Cream and Injector Sales by Country
- 9.1.1 Asia-Pacific Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Hemorrhoid Cream and Injector Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Hemorrhoid Cream and Injector Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Hemorrhoid Cream and Injector Market Size by Country
- 9.2.1 Asia-Pacific Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Hemorrhoid Cream and Injector Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Hemorrhoid Cream and Injector Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Hemorrhoid Cream and Injector Sales by Country
- 10.1.1 South America Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Hemorrhoid Cream and Injector Sales by Country (2021-2026)
- 10.1.3 South America Hemorrhoid Cream and Injector Sales Forecast by Country (2027-2032)
- 10.2 South America Hemorrhoid Cream and Injector Market Size by Country
- 10.2.1 South America Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Hemorrhoid Cream and Injector Market Size by Country (2021-2026)
- 10.2.3 South America Hemorrhoid Cream and Injector Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Hemorrhoid Cream and Injector Sales by Country
- 11.1.1 Middle East and Africa Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Hemorrhoid Cream and Injector Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Hemorrhoid Cream and Injector Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Hemorrhoid Cream and Injector Market Size by Country
- 11.2.1 Middle East and Africa Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Hemorrhoid Cream and Injector Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Hemorrhoid Cream and Injector Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Hemorrhoid Cream and Injector Value Chain Analysis
- 12.1.1 Hemorrhoid Cream and Injector Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Hemorrhoid Cream and Injector Production Mode & Process
- 12.2 Hemorrhoid Cream and Injector Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Hemorrhoid Cream and Injector Distributors
- 12.2.3 Hemorrhoid Cream and Injector Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst